For the quarter ending 2025-09-30, JUNS made $2,307,265 in revenue. -$2,288,034 in net income. Net profit margin of -99.17%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Research and development | 816,697 | 759,448 | 91,911 | |
| General and administrative | 1,480,356 | 1,505,432 | 401,636 | |
| Total operating expenses | 2,297,053 | 2,264,880 | 493,547 | |
| Gain on extinguishment of debt | - | 0 | - | |
| Loss from operations | -2,297,053 | -2,264,880 | -493,547 | |
| Loss on change in fair value of derivative liability | - | 0 | 9,885 | |
| Other income | - | 0 | - | |
| Interest income | 10,212 | 13,050 | 23 | |
| Interest expense | 1,193 | 1,135 | 107,382 | |
| Total other income (expenses), net | 9,019 | 11,915 | -97,474 | |
| Net (loss) income | -2,288,034 | -2,252,965 | -591,021 | |
| Basic | -0.07 | -0.07 | -0.02 | |
| Basic | 34,039,906 | 33,180,966 | 31,065,688 | |
| Diluted | -0.07 | -0.07 | -0.02 | |
| Diluted | 34,039,906 | 33,180,966 | 31,065,688 | |
JUPITER NEUROSCIENCES, INC. (JUNS)
JUPITER NEUROSCIENCES, INC. (JUNS)